{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:19:18Z","timestamp":1790014758819,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.yebeh.2022.108958","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T23:05:25Z","timestamp":1667084725000},"page":"108958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PA","title":["Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy"],"prefix":"10.1016","volume":"137","author":[{"given":"Vicente","family":"Villanueva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Garc\u00eda-Ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Smeyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Garc\u00eda-Pe\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gonz\u00e1lez-Alguacil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora","family":"Sayas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Serrano-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Garces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"de Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Barcel\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Aledo-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gil-Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Iacampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Falip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Ana","family":"Saiz-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asier","family":"G\u00f3mez-Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sopelana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Sanchez-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"L\u00f3pez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2022.108958_b0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE Classification of the Epilepsies position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108958_b0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1474-4422(08)70292-8","article-title":"Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology","volume":"8","author":"Arzimanoglou","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2022.108958_b0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40272-016-0171-7","article-title":"Pharmacotherapy for Dravet syndrome","volume":"18","author":"Wallace","year":"2016","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.yebeh.2022.108958_b0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.resp.2013.06.026","article-title":"Sudden unexpected death in Dravet syndrome: respiratory and other physiological dysfunctions","volume":"189","author":"Kalume","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.yebeh.2022.108958_b0025","first-page":"255","article-title":"Treatment of seizures associated with Lennox-Gastaut and Dravet syndromes: a focus on cannabidiol oral solution","volume":"44","author":"Lazaridis","year":"2019","journal-title":"Pharm Ther"},{"key":"10.1016\/j.yebeh.2022.108958_b0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yebeh.2017.02.003","article-title":"The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future research","volume":"70","author":"Jensen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108958_b0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/JMDH.S69300","article-title":"Lennox-Gastaut syndrome: Impact on the caregivers and families of patients","volume":"7","author":"Gibson","year":"2014","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.yebeh.2022.108958_b0040","unstructured":"Epidyolex. Summary of Product Characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/epidyolex-epar-product-information_en.pdf."},{"key":"10.1016\/j.yebeh.2022.108958_b0045","article-title":"Epidiolex","author":"Food","year":"2018","journal-title":"Full Prescr Inf"},{"key":"10.1016\/j.yebeh.2022.108958_b0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-319-20825-1_10","article-title":"Cannabis and endocannabinoid signaling in epilepsy","volume":"231","author":"Katona","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"21","key":"10.1016\/j.yebeh.2022.108958_b0055","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet Syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.yebeh.2022.108958_b0060","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox-Gastaut Syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"issue":"10125","key":"10.1016\/j.yebeh.2022.108958_b0065","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.yebeh.2022.108958_b0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","article-title":"Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet Syndrome: a randomized clinical trial","volume":"77","author":"Miller","year":"2020","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108958_b0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial","volume":"78","author":"Thiele","year":"2021","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.yebeh.2022.108958_b0080","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/epi.17000","article-title":"Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: results of a long-term open-label extension trial","volume":"62","author":"Patel","year":"2021","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.yebeh.2022.108958_b0085","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/epi.17036","article-title":"Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial","volume":"62","author":"Scheffer","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108958_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.673135","article-title":"Results from an Italian expanded access program on cannabidiol treatment in highly refractory Dravet Syndrome and Lennox-Gastaut Syndrome","volume":"12","author":"Iannone","year":"2021","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.yebeh.2022.108958_b0095","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/epi.14477","article-title":"Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: expanded access program results","volume":"59","author":"Szaflarski","year":"2018","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108958_b0100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108958_b0105","first-page":"415","article-title":"Experience with Health Quality of Life Questionnaire for the epileptic child (CAVE) \u2013 PubMed","volume":"25","author":"Casas-Fern\u00e1ndez","year":"1997","journal-title":"Rev Neurol"},{"key":"10.1016\/j.yebeh.2022.108958_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2019.03.015","article-title":"Long-term safety and efficacy of cannabidiol in children and adults with treatment-resistant Lennox-Gastaut Syndrome or Dravet Syndrome: Expanded access program results","volume":"154","author":"Laux","year":"2019","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108958_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.seizure.2021.05.014","article-title":"Two-center experience of cannabidiol use in adults with Dravet syndrome","volume":"91","author":"Silvennoinen","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108958_b0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2018.07.020","article-title":"Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study","volume":"87","author":"Szaflarski","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.yebeh.2022.108958_b0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/ane.13305","article-title":"Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials","volume":"142","author":"Devinsky","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2022.108958_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108538","article-title":"Effects of Epidiolex\u00ae (Cannabidiol) on seizure-related emergency department visits and hospital admissions: A retrospective cohort study","volume":"127","author":"Abu-Sawwa","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108958_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108190","article-title":"Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy","volume":"122","author":"Grayson","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108958_b0140","first-page":"S1","article-title":"Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts\u2019 recommendations for its use in clinical practice in Spain","volume":"73","author":"Garc\u00eda-Pe\u00f1as","year":"2021","journal-title":"Rev Neurol"},{"issue":"9","key":"10.1016\/j.yebeh.2022.108958_b0145","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/epi.16974","article-title":"Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials","volume":"62","author":"Madan Cohen","year":"2021","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2022.108958_b0150","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/epi.16878","article-title":"Time to onset of cannabidiol (CBD) treatment effect in Lennox-Gastaut syndrome: Analysis from two randomized controlled trials","volume":"62","author":"Privitera","year":"2021","journal-title":"Epilepsia"},{"issue":"Pt A","key":"10.1016\/j.yebeh.2022.108958_b0155","article-title":"Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy","volume":"114","author":"Metternich","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2022.108958_b0160","doi-asserted-by":"crossref","DOI":"10.1111\/epi.16596","article-title":"Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acid","volume":"61","author":"McNamara","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108958_b0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/epi.13815","article-title":"Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol","volume":"58","author":"Rosenberg","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108958_b0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2019.03.035","article-title":"Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy","volume":"95","author":"Gaston","year":"2019","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022004073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022004073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:48:06Z","timestamp":1761504486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022004073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"alternative-id":["S1525505022004073"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108958","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108958"}}